This site is intended for healthcare professionals

Specialty hub

Neurology (CNS) and Pain

Containing dedicated Learning Zones, guidelines, trials and news for related conditions in Neurology (CNS) and Pain.

Read time: 5 mins

Last updated: 14th Aug 2020

Welcome:

Sign in/Register

Updates in your area
of interest

Articles your peers
are looking at

Bookmarks
saved

Days to your
next event

Neurology is the branch of medicine that deals with conditions and diseases involving the central nervous system (brain and spinal cord) and the peripheral nervous systems (autonomic and somatic), including their coverings, blood vessels, and all effector tissue such as muscle.

Neurology encompasses over 5000 neurological diseases and relies on insights from fields such as neuroscience. This medical speciality deals with dementia including Alzheimer’s disease, Parkinson’s disease, neuromuscular disorders including spinal muscular atrophy and pain management as a sub-speciality.

Diseases in this section

Attention Deficit Hyperactivity Disorder (ADHD)

Containing relevant Learning Zones, guidelines, trials and news.

Dementia

Containing relevant Learning Zones, guidelines, trials and news.

Epilepsy

Containing relevant Learning Zones, guidelines, trials and news.

Neuromuscular Disorders

Containing relevant Learning Zones, guidelines, trials and news.

Pain

Containing relevant Learning Zones, guidelines, trials and news.

Parkinson's Disease

Containing relevant Learning Zones, guidelines, trials and news.

Learning Zones

Anticoagulation Therapy for Stroke Prevention

Learning Zone Homepage

Anticoagulation Therapy for Stroke Prevention

COMT inhibition in Parkinson’s Disease

Learning Zone Homepage

COMT inhibition in Parkinson’s Disease

Spinal Muscular Atrophy

Learning Zone Homepage

Spinal Muscular Atrophy

Neuroscience and Pain Learning Zone

Learning Zone Homepage

Neuroscience and Pain Learning Zone

Related news and insights

FDA accepts BLA from Eisai and Biogen for aducanumab, a proposed treatment for Alzheimer’s disease.

Biogen and Eisai, Co., Ltd. announced that the FDA has accepted the Biologics License Application (BLA) for aducanumab, an investigational treatment for Alzheimer’s disease.

1 mins

FDA approves Olinvyk for management of acute pain.- Trevena

The FDA has approved Olinvyk (oliceridine), from Trevena, an opioid agonist for the management of moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom alternative treatments are inadequate.

1 min

FDA approves Evrysdi (risdiplam) for treatment of spinal muscular atrophy (SMA) in adults and children 2 months and older. Genentech/Roche

Genentech, a member of the Roche Group , announced that the FDA has approved Evrysdi (risdiplam) for treatment of spinal muscular atrophy (SMA) in adults and children 2 months of age and older.

1 min

See all news

Related drugs

Levetiracetam Mylan 1000 mg film-coated tablets

Levetiracetam Mylan 1000 mg film-coated tablets

Zebinix 800 mg tablets

Zebinix 800 mg tablets

Pregabalin Tillomed 75 mg capsules, hard

Pregabalin Tillomed 75 mg capsules, hard

Pregabalin Tillomed 50 mg capsules, hard

Pregabalin Tillomed 50 mg capsules, hard

Pregabalin Tillomed 300 mg capsules, hard

Pregabalin Tillomed 300 mg capsules, hard

Pregabalin Tillomed 25 mg capsules, hard

Pregabalin Tillomed 25 mg capsules, hard

Pregabalin Tillomed 225 mg capsules, hard

Pregabalin Tillomed 225 mg capsules, hard

Pregabalin Tillomed 200 mg capsules, hard

Pregabalin Tillomed 200 mg capsules, hard

Pregabalin Tillomed 150 mg capsules, hard

Pregabalin Tillomed 150 mg capsules, hard

Pregabalin Tillomed 100 mg capsules, hard

Pregabalin Tillomed 100 mg capsules, hard

Solpadeine Plus Tablets

Solpadeine Plus Tablets

Solpadeine Plus Capsules

Solpadeine Plus Capsules

solpadeine max tablets

solpadeine max tablets

Paramol Tablets

Paramol Tablets

Related Guidelines

Cannabis-based medicinal products

This guideline covers prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy.

1 mins

Risk reduction and management of delirium

This guideline provides recommendations based on current evidence for best practice in the detection, assessment, treatment and follow up of adults with delirium, as well as reducing the risk of delirium.

1 min

Pharmacological management of migraine

This guideline provides recommendations on the pharmacological management of adults with acute migraine, and prophylaxis for patients with episodic or chronic migraine or medication overuse headache.

1 min

See all guidelines

Your peers are looking at...

FDA accepts application for Xolair prefilled syringe for self-administration across all indications. Novartis

FDA accepts application for Xolair prefilled syringe for self-administration across all indications. Novartis

1 mins

Results from the Phase III VIALE-A clinical study of Venclexta with Vidaza in acute myeloid leukemia (AML) in NEJM.- AbbVie

Results from the Phase III VIALE-A clinical study of Venclexta with Vidaza in acute myeloid leukemia (AML) in NEJM.- AbbVie

1 mins

Thermo Fisher acquisition of Qiagen will not proceed

Thermo Fisher acquisition of Qiagen will not proceed

1 mins

VBL Therapeutics announces second successful pre-planned interim analysis with a positive data safety monitoring committee review looking at OS - the primary endpoint of the OVAL Phase III potential registration study of VB 111 in Ovarian Cancer.

VBL Therapeutics announces second successful pre-planned interim analysis with a positive data safety monitoring committee review looking at OS - the primary endpoint of the OVAL Phase III potential registration study of VB 111 in Ovarian Cancer.

1 mins

Australia joins U.S., Switzerland, Canada and Singapore in approval of
Tukysa for the treatment of patients with locally advanced or metastatic HER2-positive breast cancer - Seattle Genetics

Australia joins U.S., Switzerland, Canada and Singapore in approval of Tukysa for the treatment of patients with locally advanced or metastatic HER2-positive breast cancer - Seattle Genetics

1 mins

Tyvyt filed in China for squamous non-small cell lung cancer.- Innovent Biologics + Eli Lilly

Tyvyt filed in China for squamous non-small cell lung cancer.- Innovent Biologics + Eli Lilly

1 mins

Bayer HealthCare acquires KaNDy Therapeutics and with it NT 814 to treat menopause

Bayer HealthCare acquires KaNDy Therapeutics and with it NT 814 to treat menopause

1 mins

CheckMate -649, a phase III trial of Opdivo + chemotherapy vs. chemotherapy, meets primary endpoints of superior overall survival and progression-free survival in first-line treatment of gastric and esophageal cancers. BMS

CheckMate -649, a phase III trial of Opdivo + chemotherapy vs. chemotherapy, meets primary endpoints of superior overall survival and progression-free survival in first-line treatment of gastric and esophageal cancers. BMS

1 mins

Guardant360 CDx first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers. Guardant Health, Inc.

Guardant360 CDx first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers. Guardant Health, Inc.

1 mins

European Commission approves Xolair as an add-on therapy with intranasal corticosteroids for the treatment of severe chronic rhinosinusitis with nasal polyps. - Novartis

European Commission approves Xolair as an add-on therapy with intranasal corticosteroids for the treatment of severe chronic rhinosinusitis with nasal polyps. - Novartis

1 mins

Related Journals

The Association Between Vitamin D Status, Vitamin D Supplementation, Sunlight Exposure, and Parkinson's Disease: A Systematic Review and Meta-Analysis.

The Association Between Vitamin D Status, Vitamin D Supplementation, Sunlight Exposure, and Parkinson's Disease: A Systematic Review and Meta-Analysis.

1 mins

Assessing pain in non-intubated critically ill patients unable to self report: an adaptation of the Behavioral Pain Scale.

Assessing pain in non-intubated critically ill patients unable to self report: an adaptation of the Behavioral Pain Scale.

1 mins

Emergency Management of Epilepsy and Seizures.

Emergency Management of Epilepsy and Seizures.

1 mins

Executive function in eating disorders: The role of state anxiety

Executive function in eating disorders: The role of state anxiety

1 mins

Alemtuzumab depletion failure can occur in multiple sclerosis.

Alemtuzumab depletion failure can occur in multiple sclerosis.

1 mins

Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage.

Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage.

1 mins

Neuropathology of Alzheimer's disease.

Neuropathology of Alzheimer's disease.

1 mins

Therapeutic Monoclonal Antibodies: What Headache Specialists Need to Know.

Therapeutic Monoclonal Antibodies: What Headache Specialists Need to Know.

1 mins

Association of White Matter Structure With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.

Association of White Matter Structure With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.

1 mins

Methylphenidate hydrochloride modified-release in adults with attention deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial.

Methylphenidate hydrochloride modified-release in adults with attention deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial.

1 mins

Related Events

BNA 2021 Festival Of Neuroscience

BNA 2021 Festival Of Neuroscience

European Neurosurgery 2021

European Neurosurgery 2021

World Congress for Brain Mapping and Therapeutics of SBMT 2021 (SBMT 2021)

World Congress for Brain Mapping and Therapeutics of SBMT 2021 (SBMT 2021)

Related Clinical Trials

An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis (TOWER)

An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis (TOWER)

3 mins

Identification of a Biomarker Predictive of Evolution of Parkinson Disease (GLIAPARK)

Identification of a Biomarker Predictive of Evolution of Parkinson Disease (GLIAPARK)

3 mins

Efficacy and Safety of Ofatumumab Compared to Placebo in Patients With Relapsing Multiple Sclerosis Followed by Extended Treatment With Open-label Ofatumumab

Efficacy and Safety of Ofatumumab Compared to Placebo in Patients With Relapsing Multiple Sclerosis Followed by Extended Treatment With Open-label Ofatumumab

3 mins

Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults (GWPCARE3)

Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults (GWPCARE3)

4 mins

Simvastatin in Secondary Progressive Multiple Sclerosis (MS-OPT)

Simvastatin in Secondary Progressive Multiple Sclerosis (MS-OPT)

3 mins

Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ?1 Month to <4 Years With Partial-onset Seizures

Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ?1 Month to <4 Years With Partial-onset Seizures

3 mins

Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin (PEGASUS)

Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin (PEGASUS)

1 mins

A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS) (CLARITY)

A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS) (CLARITY)

2 mins

Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine

Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine

2 mins

Study to Evaluate Oral BIIB061 Added to Interferon-beta1 (IFN-β1) in Relapsing Multiple Sclerosis (RMS)

Study to Evaluate Oral BIIB061 Added to Interferon-beta1 (IFN-β1) in Relapsing Multiple Sclerosis (RMS)

3 mins

Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063) (ENLIGHTEN)

Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063) (ENLIGHTEN)

3 mins

Impact of Bosutinib on Safety, Tolerability, Biomarkers and Clinical Outcomes in Dementia With Lewy Bodies

Impact of Bosutinib on Safety, Tolerability, Biomarkers and Clinical Outcomes in Dementia With Lewy Bodies

4 mins